Thomas Ramey Watson

Low-dose aspirin cuts risk of colorectal cancer by a third

Researchers in Scotland conducted a study

in which they found low-dose aspirin used regularly can cut the risk of colorectal cancer by a third.

After just one year of taking a daily dose of 75 milligrams, patients had reduced their colon cancer risk by 13 percent, the study found.

After five years of taking the same daily dose,

the risk was reduced by 37 percent.

Read more.

Leave a Comment

Your email address will not be published.